Logo image of COEP

COEPTIS THERAPEUTICS HOLDING (COEP) Stock Analyst Earnings Estimates

NASDAQ:COEP - Nasdaq - US19207A1088 - Common Stock - Currency: USD

12.39  +1.18 (+10.53%)

After market: 12.99 +0.6 (+4.84%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
COEP revenue by date.COEP revenue by date.
75K
-100.00%
1.785M50.174M4.386M
-91.26%
20.808M
374.42%
58.242M
179.90%
EBITDA
YoY % growth
COEP ebitda by date.COEP ebitda by date.
N/AN/A-13.599M
-144.10%
5.202M
38.27%
6.018M
129.37%
7.038M
16.95%
-20.094M
-385.51%
-20.4M
-1.52%

100.00%
4.08M17.442M
327.50%
EBIT
YoY % growth
COEP ebit by date.COEP ebit by date.
-100-566.68K
-566,580.00%
-14.046M
-2,378.64%
-2.346M
-143.46%
-18.39M
37.15%
-12.435M
42.14%
-15.691M
-26.18%
-17.584M
-12.07%
-19.716M
-12.12%
-71.298M
-261.63%
-63.24M
11.30%
-35.19M
44.35%
Operating Margin
COEP operating margin by date.COEP operating margin by date.
N/AN/A-18,727.92%N/A-1,030.26%N/AN/AN/A-39.29%-1,625.58%-303.92%-60.42%
EPS
YoY % growth
COEP eps by date.COEP eps by date.
N/AN/AN/A0.17-0.87
-600.00%
-0.27
69.41%
-0.17
34.62%
-0.17-0.18
-5.88%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.04
62.91%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-3.24M
3.76%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.05
78.26%
-0.050.001.96%
Q2 2024
Q2Q % growth
-0.08
60.78%
-0.090.0112.85%
Q4 2023
Q2Q % growth
-0.11
95.75%
-0.120.0110.13%
Q3 2023
Q2Q % growth
-0.23 -0.01-0.22-2,154.90%
Q1 2023
Q2Q % growth
-0.39 -0.29-0.10-36.55%
Q4 2022
Q2Q % growth
-2.59 -0.08-2.51-3,074.02%
COEP Yearly EPS VS EstimatesCOEP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4 -0.6 -0.8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
3.57M-3.57M-100.00%
COEP Yearly Revenue VS EstimatesCOEP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A N/A N/A